New Jersey’s pharma sector faces new layoffs as Merck cuts 204 jobs and Bristol Myers Squibb plans 110 reductions amid ...
Opinion
Zacks Investment Research on MSNOpinion

Top Analyst Reports for Visa, Merck & Southern Company

Thursday, November 20, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc.
Merck KGaA, Darmstadt, Germany, has collaborated with Lenovo Group Ltd. and Equinix Inc. to successfully launch a state-of-the-art high-performance ...
Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.
Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...
Apple became the first $1 trillion company on U.S. public markets in 2018. Six of the eight companies to follow in Apple’s ...
Over the past two years, Merck ( MRK 0.19%) has faced several challenges, resulting in a decline in the company's share price ...
Merck has announced plans to acquire Cidara Therapeutics for $9.2 billion, or $221.50 per share. Representing a heavy premium ...
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the ...
Valo Health Inc. is in line for upfront and potential milestone payments totaling up to over $3 billion under its new ...
Uncover the GDL Fund's Q3 2025 report, M&A volume, and top performers. Get insights on regulatory environment, financing ...
Regulators approved the injection, which significantly cuts administration time versus the intravenous formulation, based on a Phase III comparison of the two.